| Date | Form | Description | Docs | XBRL | Pages |
| 10/02/15 | 8-K | Current report filing |
|
40 | |
| 10/02/15 | 424B5 | Prospectus filed pursuant to Rule 424(b)(5) |
|
43 | |
| 09/29/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/29/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/29/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/23/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/23/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/21/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 09/18/15 | EFFECT | Notice of Effectiveness |
|
1 | |
| 09/18/15 | 4 | Statement of changes in beneficial ownership of securities |
|
2 |
Latest News & Events
Anixa Biosciences Announces Dr. Jose Conejo-Garcia will Keynote the South Carolina Clinical & Translational Research Institute 2026 Retreat
Read More...Anixa Biosciences Reports Encouraging Patient Survival Observations in Ovarian Cancer CAR-T Trial; Achieves Regulatory Approval Enabling Major Dose Escalation
Read More...Anixa Biosciences Secures United States Adopted Names Council Approval of Non-Proprietary Name for its CAR-T Therapy, a Key Step Toward Future Commercialization
Read More...